China Regenerative Medicine International (08158) Releases Monthly Return Showing Unchanged Issued Shares
Bulletin Express
Nov 04
China Regenerative Medicine International Limited (stock code: 08158) released its monthly return for the period ended 31 October 2025. The authorized share capital remained at 5,000,000,000 ordinary shares with a par value of HKD 0.20 per share, totaling HKD 1,000,000,000. The number of issued shares held steady at 304,252,480, with no treasury shares reported.
The announcement also indicated the existence of a new share option scheme under which 30,425,248 shares may potentially be issued, though no options were exercised and no new funds were raised during this period. No other movements—such as warrants, convertibles, or other share issuance agreements—were noted in the disclosure.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.